Ryan Moy
@RyanMoyMDPhD
Asst Professor, GI oncologist @columbiacancer. Former med onc fellow @sloan_kettering. 🏳️🌈 Runner 🏃🏻, 🦮🌿 dad.
Excited to share our study led by fellow Lawrence Wu, focusing on the molecular characterization of early-onset esophagogastric cancer. We explore transcriptional profiles, immune microenvironment, and real-world survival outcomes. rdcu.be/ewEsO
Dr. Lawrence Wu presenting our work on clinicogenomic profiling of signet ring carcinoma across organ sites. Awarded both an ASCO Conquer Cancer Foundation Merit Award and CAHON Young Investigator Award! #ASCO25
Super⭐️ oncology fellow Lawrence Wu presenting work on TEAD inhibition in diffuse gastric cancer #AACR
Sungjoo Jang presenting our work on PKMYT1 inhibition in CCNE1-amplified gastric cancer. Thankful for grant funding from AACR and Debbie’s Dream Foundation to support this work! @StomachCancer_
Our analysis of Claudin18.2 expression in gastroesophageal adenocarcinoma in a diverse patient cohort with higher positivity in Hispanic patients. Presented by Dr. Sara Wallam who is applying for heme/onc fellowship this cycle!
Running the CUIMC Team Relay Marathon for team Cure Stomach Cancer with Moy and Ryeom lab members
Look at this!! 👀 New trends in cancer cases show a major change in #StomachCancer in women especially. We need more research to understand the causes for this. #CancerResearch @theNCI @NoStomach4Cancr @StomachCancer_ @UMGCCC
Always a pleasure to chair a meeting with @YJanjigianMD! Please join us for our 1st combined solid tumor hybrid meeting: Great Debates in Solid Tumors. @GreatDebatesCME Register: hmpglobalevents.com/gdst/agenda 🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
Excited to share biomarker analysis of CM649 @NatureMedicine @YJanjigianMD Nivo benefit was enriched in TMB-H> EBV and GS > CIN. Targeted tx is needed for CIN. Nivo+Ipi benefit was seen in Treg↑ (FOXP3+CCR8), supporting Treg or CCR8 targeting tx in GC. nature.com/articles/s4159…
Science in Society: Strengthening Asian/Asian American, Native Hawaiian, and Pacific Islander Leadership in Cancer Research aacrjournals.org/cancerdiscover… By Lawrence Wu and @RyanMoyMDPhD, on behalf of the AACR #AANHPI Task Force @columbiacancer
Still a few days left for Stomach Cancer Awareness Month! Thank you @columbiacancer for highlighting our investigator-initiated trial for diffuse-type gastric cancer, as well as research in young-onset cancer led by fellow Lawrence Wu cancer.columbia.edu/news/promising…
Look at this amazing group for @GreatDebatesCME #GDUGI Day 1. PHENOMENAL speakers. 🙏🙏 🤩@YJanjigianMD @rachnatshroff @HKennecke @smitha42 @MallaMidhun @smitha42 @KristenCiombor @RyanMoyMDPhD @DrJZell ❤️ this group!!! #cancer #canceresearch
Great to have another option for patients. @KoheiShitara @mdmanishshah @ILSONDavid @FlorianLordick @sara_lonardi1 and many others. FDA Approves Zolbetuximab Plus Chemo for CLDN18.2+ Gastric or GEJ Adenocarcinoma onclive.com/view/fda-appro… via @onclive
On the way to Dallas for Great Debates & Updates GI Malignancies. Looking forward to some great discussions. hmpglobalevents.com/gdugi
Comprehensive review of diffuse gastric cancer and emerging therapies written by our fellow Lawrence Wu. rdcu.be/dTVry
Thanks @AACR and @StomachCancer_ for supporting our labs work on gastric cancer! Amazing inaugural AACR grantee summit
AACR Grantee Summit cochair Manuel Hidalgo, MD, PhD, recognized the four winners of the Poster Session. Congratulations to the winners and all those who presented their science yesterday. @WeillCornell #AACRGrants
